Home The Word Brain My Amedeo FAQ Privacy About   


C49

In our changing world, speaking just English isn't enough. Open new doors with skills in another world language.

Start with 7 words a day.

Next week: +49.


  Influenza

  Free Subscription


Articles published in J Exp Med

Retrieve available abstracts of 21 articles:
HTML format



Single Articles


    July 2025
  1. SAIDOUNE F, Lee D, Di Domizio J, Le Floc'h C, et al
    Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblains.
    J Exp Med. 2025;222:e20231467.
    PubMed     Abstract available


  2. MATZ HC, Ellebedy AH
    Vaccination against influenza viruses annually: Renewing or narrowing the protective shield?
    J Exp Med. 2025;222:e20241283.
    PubMed     Abstract available


    June 2025
  3. GROEN K, Kuratli R, Enkelmann J, Fernbach S, et al
    Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design.
    J Exp Med. 2025;222:e20242039.
    PubMed     Abstract available


  4. MADSEN A, Okba NMA, Pholcharee T, Matz HC, et al
    Identification of a seasonal influenza vaccine-induced broadly protective neuraminidase antibody.
    J Exp Med. 2025;222:e20241930.
    PubMed     Abstract available


    January 2025
  5. VALERI E, Kajaste-Rudnitski A
    Antiviral immunity lassoed down by excess RNA.
    J Exp Med. 2025;222:e20241743.
    PubMed     Abstract available


    December 2024
  6. BELLOS E, Santillo D, Vantourout P, Jackson HR, et al
    Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C).
    J Exp Med. 2024;221:e920240699.
    PubMed     Abstract available


    October 2024
  7. JEGER-MADIOT R, Planas D, Staropoli I, Debarnot H, et al
    Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boosting.
    J Exp Med. 2024;221:e20240289.
    PubMed     Abstract available


    September 2024
  8. ZANONI I
    Kids' noses resist COVID-19.
    J Exp Med. 2024;221:e20241027.
    PubMed     Abstract available


  9. WATKINS TA, Green AB, Amat JAR, Cheemarla NR, et al
    High burden of viruses and bacterial pathobionts drives heightened nasal innate immunity in children.
    J Exp Med. 2024;221:e20230911.
    PubMed     Abstract available


  10. CHAN YH, Lundberg V, Le Pen J, Yuan J, et al
    SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiency.
    J Exp Med. 2024;221:e20231725.
    PubMed     Abstract available


  11. FERNBACH S, Mair NK, Abela IA, Groen K, et al
    Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies.
    J Exp Med. 2024;221:e20240365.
    PubMed     Abstract available


    August 2024
  12. MCINTIRE KM, Meng H, Lin TH, Kim W, et al
    Maturation of germinal center B cells after influenza virus vaccination in humans.
    J Exp Med. 2024;221:e20240668.
    PubMed     Abstract available


    July 2024
  13. MACLEAN AJ, Bonifacio JPPL, Oram SL, Mohsen MO, et al
    Regulation of pulmonary plasma cell responses during secondary infection with influenza virus.
    J Exp Med. 2024;221:e20232014.
    PubMed     Abstract available


    June 2024
  14. WU TT, Travaglini KJ, Rustagi A, Xu D, et al
    Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung.
    J Exp Med. 2024;221:e20232192.
    PubMed     Abstract available


    February 2024
  15. BASTARD P, Gervais A, Taniguchi M, Saare L, et al
    Higher COVID-19 pneumonia risk associated with anti-IFN-alpha than with anti-IFN-omega auto-Abs in children.
    J Exp Med. 2024;221:e20231353.
    PubMed     Abstract available


    November 2023
  16. RUTERBUSCH MJ, Hondowicz BD, Takehara KK, Pruner KB, et al
    Allergen exposure functionally alters influenza-specific CD4+ Th1 memory cells in the lung.
    J Exp Med. 2023;220:e20230112.
    PubMed     Abstract available


    September 2023
  17. WANG Z, Muecksch F, Raspe R, Johannsen F, et al
    Memory B cell development elicited by mRNA booster vaccinations in the elderly.
    J Exp Med. 2023;220:e20230668.
    PubMed     Abstract available


    August 2023
  18. RYBKINA K, Bell JN, Bradley MC, Wohlbold T, et al
    SARS-CoV-2 infection and recovery in children: Distinct T cell responses in MIS-C compared to COVID-19.
    J Exp Med. 2023;220:e20221518.
    PubMed     Abstract available


  19. LIN YS, Chang YC, Chao TL, Tsai YM, et al
    The Src-ZNRF1 axis controls TLR3 trafficking and interferon responses to limit lung barrier damage.
    J Exp Med. 2023;220:e20220727.
    PubMed     Abstract available


  20. GILBERTSON B, Subbarao K
    Mammalian infections with highly pathogenic avian influenza viruses renew concerns of pandemic potential.
    J Exp Med. 2023;220:e20230447.
    PubMed     Abstract available


    May 2023
  21. GARCIA-GARCIA A, Perez de Diego R, Flores C, Rinchai D, et al
    Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia.
    J Exp Med. 2023;220:e20220170.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.